Flow cytometry reimbursement for CMS 1500 / UB04
Defines UnitedHealthcare reimbursement methodology and limits for flow cytometry (immunophenotyping, cell enumeration, DNA analysis) billed on CMS-1500 or UB04 forms for Commercial and Individual Exchange plans; applies to all providers submitting such claims.
No material clinical or coverage changes in this revision.
Trek Health ingests and normalizes Transparency in Coverage data and payer policy updates to give provider organizations a clear view of how commercial reimbursement behaves across markets, payers, and services. Our platform transforms raw payer disclosures into structured intelligence that supports contract evaluation, payer negotiations, and service line strategy. By combining market benchmarks with ongoing policy visibility, Trek helps teams identify variability, risk, and opportunity in commercial reimbursement. The result is faster insight, stronger negotiating positions, and more informed financial decisions.